# RAB3IP

## Overview
RAB3IP is a gene located on chromosome 12, region q13-q15, that encodes the RAB3A interacting protein, a guanine nucleotide exchange factor (GEF) involved in intracellular vesicle trafficking and membrane dynamics. The RAB3IP protein facilitates the exchange of GDP for GTP in RAB proteins, which is essential for their activation and subsequent role in vesicular transport processes (de2002The). This protein is predominantly localized in the cytoplasm but can also be found in the nucleus under certain conditions, particularly when coexpressed with the cancer-related nuclear protein SSX2 (de2002The). RAB3IP is expressed in various tissues, including the brain, kidney, heart, placenta, and pancreas, but is absent in skeletal muscle and liver, suggesting its role as a housekeeping gene (de2002The). The gene's location in a chromosomal region often associated with cancer amplifications or rearrangements indicates its potential involvement in oncogenesis (de2002The).

## Structure
The RAB3IP protein is encoded by the RAB3IP gene located on chromosome 12, region q13-q15, and is expressed in various tissues such as the brain, kidney, heart, placenta, and pancreas (de2002The). The gene comprises 12 exons and undergoes extensive alternative splicing, resulting in six different isoforms (de2002The). Notably, the RAB3IPα1 isoform encodes a protein of 460 amino acids with a predicted molecular weight of 51 kDa, while the RAB3IPγ isoform results in a truncated protein of 304 amino acids due to a frameshift (de2002The).

The RAB3IP protein features a high alpha-helical and coiled-coil potential between amino acids 150 and 250, and contains an endoplasmic reticulum retention motif at the C-terminal (de2002The). It also has a potential bipartite nuclear localization signal between amino acids 377 and 393 (de2002The). The protein is subject to several potential post-translational modifications, including N-glycosylation, protein kinase C phosphorylation, casein kinase II phosphorylation, tyrosine kinase phosphorylation, and N-myristoylation (de2002The).

RAB3IP functions as a guanine nucleotide exchange factor (GEF) for Rab3A, playing a role in vesicle trafficking and membrane dynamics (Park2013Structural). The protein predominantly localizes in the cytoplasm but can also be found in the nucleus when coexpressed with SSX2 (de2002The).

## Function
RAB3IP, also known as RAB3A interacting protein, is involved in intracellular vesicle trafficking and membrane dynamics. It functions as a guanine nucleotide exchange factor (GEF) for RAB proteins, facilitating the exchange of GDP for GTP, which is crucial for the activation of RAB proteins involved in vesicular transport processes (de2002The). The RAB3IP protein is predominantly found in the cytoplasm but can colocalize with SSX2 in the nucleus under certain conditions, indicating its potential role in nuclear processes (de2002The).

RAB3IP is expressed ubiquitously in various tissues, including the brain, kidney, heart, placenta, and pancreas, but is not expressed in skeletal muscle and liver (de2002The). Its widespread expression suggests it may function as a housekeeping gene, potentially involved in vesicular transport processes (de2002The). In testicular cells, RAB3IP may shuttle between the nucleus and cytoplasm, interacting with testis-expressed Rab3 isoforms or GTPases in the cytoplasm and with SSX2 in the nucleus, suggesting a potential role in cell-cycle-related processes (de2002The). The gene is located on chromosome 12q13-14, a region often amplified or rearranged in cancers, indicating a possible involvement in cancer development (de2002The).

## Clinical Significance
RAB3IP has been identified as a novel oncogene in ovarian cancer, where its high expression is associated with poor prognosis and shorter overall survival. Studies have shown that RAB3IP is significantly overexpressed in ovarian cancer tissues compared to normal tissues, and its knockdown reduces cell viability, proliferation, and migration. Genetic alterations, particularly amplification, are common in ovarian cancer, and certain genes are more likely to be mutated in cases with high RAB3IP expression (Li2024Identification).

In prostate cancer, circRAB3IP, a circular RNA derived from the RAB3IP gene, is implicated in enzalutamide resistance. It acts as a miRNA sponge, affecting miR-133a-3p and miR-133b, which target the SGK1 gene. This pathway is linked to tumor growth and chemoresistance, and circRAB3IP's overexpression promotes resistance to enzalutamide, a common therapeutic agent for prostate cancer (Chen2021The).

RAB3IP is also involved in neuronal damage mechanisms. In Parkinson's disease models, the LINC00943/miR-15b-5p/RAB3IP axis plays a role in neuronal injury. LINC00943 knockdown increases miR-15b-5p expression, reducing RAB3IP levels and mitigating neuronal damage (Meng2020LINC00943).

## Interactions
RAB3IP, also known as RAB3A interacting protein, is involved in several protein interactions that are significant for its role in cellular processes. It interacts with the SSX2 protein, a cancer-related nuclear protein, through its N-terminal domain. This interaction was identified using yeast two-hybrid assays and confirmed by glutathione-S-transferase pull-down assays, indicating a direct interaction between RAB3IP and SSX2. The interaction is particularly strong with a specific deletion mutant of SSX2, suggesting that the minimal RAB3IP-interacting domain is within amino acids 25 to 80 of SSX2 (de2002The).

RAB3IP is predominantly localized in the cytoplasm but can colocalize with SSX2 in the nucleus when coexpressed, suggesting a potential role in nuclear processes. This colocalization occurs in about 10% of cells, as observed through enhanced green fluorescent protein (EGFP) tagging (de2002The). RAB3IP also interacts with SSX2IP, another nuclear protein, which may play a role in nuclear architecture (de2002The).

In the context of cancer, RAB3IP has been identified as a novel oncogene in ovarian cancer, where it enhances the invasiveness of cancer cells through its interaction with SSX2 (Li2024Identification). Additionally, microRNA-126 (miR-126) has been shown to target RAB3IP, regulating its expression and thereby influencing cell viability and apoptosis in ischemia/reperfusion injury models (Sun2021MicroRNA‑126).


## References


[1. (de2002The) Diederik R.H. de Bruijn, Nuno R. dos Santos, Ellen Kater‐Baats, José Thijssen, Lieke van den Berk, Jiska Stap, Matthé Balemans, Marga Schepens, Gerard Merkx, and Ad Geurts van Kessel. The cancer‐related protein ssx2 interacts with the human homologue of a ras‐like gtpase interactor, rab3ip, and a novel nuclear protein, ssx2ip. Genes, Chromosomes and Cancer, 34(3):285–298, March 2002. URL: http://dx.doi.org/10.1002/gcc.10073, doi:10.1002/gcc.10073. This article has 47 citations.](https://doi.org/10.1002/gcc.10073)

2. (Li2024Identification) Identification of RAB3IP as a novel oncogene related to ovarian cancer. This article has 0 citations.

[3. (Meng2020LINC00943) Chunming Meng, Jing Gao, Qingyuan Ma, Qian Sun, and Tiantian Qiao. Linc00943 knockdown attenuates mpp+-induced neuronal damage via mir-15b-5p/rab3ip axis in sk-n-sh cells. Neurological Research, 43(3):181–190, November 2020. URL: http://dx.doi.org/10.1080/01616412.2020.1834290, doi:10.1080/01616412.2020.1834290. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/01616412.2020.1834290)

[4. (Chen2021The) Dong Chen, Yaqin Wang, Feiya Yang, Adili Keranmu, Qingxin Zhao, Liyuan Wu, Sujun Han, and Nianzeng Xing. The circrab3ip mediated by eif4a3 and lef1 contributes to enzalutamide resistance in prostate cancer by targeting mir-133a-3p/mir-133b/sgk1 pathway. Frontiers in Oncology, November 2021. URL: http://dx.doi.org/10.3389/fonc.2021.752573, doi:10.3389/fonc.2021.752573. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.752573)

[5. (Sun2021MicroRNA‑126) Zhumei Sun, Xu Zhao, Meihang Zhang, Ning Li, Yanning Zhao, Changxiang Chen, Jianmin Li, Yanjuan Guo, and Qiang Feng. Microrna‑126 protects sh‑sy5y cells from ischemia/reperfusion injury‑induced apoptosis by inhibiting rab3ip. Molecular Medicine Reports, December 2021. URL: http://dx.doi.org/10.3892/mmr.2021.12578, doi:10.3892/mmr.2021.12578. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2021.12578)

[6. (Park2013Structural) Hyun Park. Structural basis of membrane trafficking by rab family small g protein. International Journal of Molecular Sciences, 14(5):8912–8923, April 2013. URL: http://dx.doi.org/10.3390/ijms14058912, doi:10.3390/ijms14058912. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms14058912)